Alterations in cancer cell metabolism: the Warburg effect and metabolic adaptation

Genomics
Yazdan AsgariAli Masoudi-Nejad

Abstract

The Warburg effect means higher glucose uptake of cancer cells compared to normal tissues, whereas a smaller fraction of this glucose is employed for oxidative phosphorylation. With the advent of high throughput technologies and computational systems biology, cancer cell metabolism has been reinvestigated over the last decades toward identifying various events underlying "how" and "why" a cancer cell employs aerobic glycolysis. Significant progress has been shaped to revise the Warburg effect. In this study, we have integrated the gene expression of 13 different cancer cells with the genome-scale metabolic network of human (Recon1) based on the E-Flux method, and analyzed them based on constraint-based modeling. Results show that regardless of significant up- and down-regulated metabolic genes, the distribution of metabolic changes is similar in different cancer types. These findings support the theory that the Warburg effect is a consequence of metabolic adaptation in cancer cells.

References

Jun 29, 2002·Nature Biotechnology·Bernhard Palsson
Feb 24, 1956·Science·O WARBURG
Oct 29, 2003·Current Opinion in Biotechnology·Kenneth J KauffmanJeremy S Edwards
May 14, 2004·Proceedings of the National Academy of Sciences of the United States of America·Tetsufumi KoikeReiji Kanangi
Nov 10, 2004·Genomics·B Altenberg, K O Greulich
Dec 6, 2005·Nature Reviews. Cancer·Eyal Gottlieb, Ian P M Tomlinson
Oct 5, 2006·Molecular Cell·Andreas G Ladurner
Feb 3, 2007·Proceedings of the National Academy of Sciences of the United States of America·Natalie C DuarteBernhard Ø Palsson
Apr 5, 2008·Current Opinion in Genetics & Development·Ralph J DeberardinisCraig B Thompson
Feb 10, 2009·Current Opinion in Genetics & Development·Xuemei TongCraig B Thompson
Mar 10, 2009·Genes & Development·Russell G Jones, Craig B Thompson
Oct 29, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Chi V DangPing Gao
Jan 9, 2010·Nature Protocols·Ines Thiele, Bernhard Ø Palsson
May 1, 2010·Current Opinion in Microbiology·Adam M Feist, Bernhard O Palsson
May 13, 2010·BMC Systems Biology·Alexei VazquezZoltán N Oltvai
Jun 1, 2010·Bioinformatics·Aris FloratosAndrea Califano
Jul 24, 2010·BMC Bioinformatics·Tong HaoIgor Goryanin
Sep 3, 2010·PloS One·Osbaldo Resendis-AntonioSergio Encarnación
Nov 19, 2010·BMC Systems Biology·Arnau MontagudKiran Raosaheb Patil
Jun 23, 2011·Molecular Systems Biology·Ori FolgerTomer Shlomi
Aug 4, 2011·Molecular Systems Biology·Roger L ChangJason A Papin
Sep 21, 2011·Proceedings of the National Academy of Sciences of the United States of America·Cen ZhangZhaohui Feng
Feb 4, 2012·Cancer Prevention Research·Matthew L SilvieraCarmen Sapienza
Mar 13, 2012·Seminars in Cell & Developmental Biology·Steven J Bensinger, Heather R Christofk
Aug 14, 2012·International Journal of Cell Biology·Simone Cardaci, Maria Rosa Ciriolo
Aug 28, 2012·Nature Chemical Biology·Dimitrios AnastasiouMatthew G Vander Heiden
Aug 31, 2012·Frontiers in Physiology·Anna S Blazier, Jason A Papin
Sep 11, 2012·Briefings in Functional Genomics·Vuk Janjić, Nataša Pržulj
Nov 8, 2012·Briefings in Bioinformatics·Meiyappan LakshmananDong-Yup Lee
Nov 20, 2012·Pharmacology & Therapeutics·Mohita UpadhyayPerumal Vivekanandan
Dec 14, 2012·BMC Systems Biology·Yuliang WangNathan D Price
Mar 5, 2013·Nature Biotechnology·Ines ThieleBernhard Ø Palsson

❮ Previous
Next ❯

Citations

Jul 21, 2015·International Journal of Molecular Sciences·Shiyan YanJiangao Fan
Jul 7, 2015·FEBS Letters·Cristina MarantoAgata Giallongo
Jun 23, 2016·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Paramasivan PoornimaThomas Efferth
Aug 21, 2016·The Journal of Investigative Dermatology·Thomas M Rünger
May 23, 2017·Nature Communications·Prabir K ChakrabortyPriyabrata Mukherjee
Jan 26, 2017·Scientific Reports·Daniel C ZielinskiBernhard O Palsson
Jan 20, 2018·Integrative Biology : Quantitative Biosciences From Nano to Macro·Yazdan AsgariMahnaz Habibi
Oct 20, 2018·Current Cancer Drug Targets·Richard L Carpenter, Yesim Gökmen-Polar
Mar 9, 2018·Oncotarget·Lucía Trilla-FuertesJuan Ángel Fresno Vara
May 20, 2017·Oncotarget·Medhi WangpaichitrNiramol Savaraj
Jun 4, 2019·Endocrinology·Malachi A Blundon, Subhamoy Dasgupta
Mar 18, 2020·Endocrine Reviews·Alexis Diaz-VegasSergio Lavandero
Apr 3, 2019·Endocrine·Raziyeh AbooshahabMehdi Hedayati
Jul 5, 2017·Frontiers in Oncology·Eric EidelmanMohummad Minhaj Siddiqui
Aug 23, 2020·Nature Communications·Qin WuCheryl H Arrowsmith
Oct 31, 2019·World Journal of Gastrointestinal Oncology·Keun-Yeong Jeong
Dec 7, 2018·International Journal of Molecular Sciences·Zijin LiuGenfa Zhang
Jan 10, 2020·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Minoo HamrazFrédéric Bouillaud
Dec 6, 2019·Cell Death & Disease·Kathleen SchmitCarine Michiels
Sep 10, 2020·Infection and Immunity·Rachel J Ende, Isabelle Derré
Dec 11, 2020·Cancer Control : Journal of the Moffitt Cancer Center·Erliang GuoSusheng Miao
May 22, 2019·Microbiology Spectrum·Marion RotherThomas Rudel
Jul 3, 2021·Journal of Personalized Medicine·Mahdi JaliliAli Salehzadeh-Yazdi
Aug 19, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Rodrigo Pinheiro AraldiEdislane Barreiros de Souza

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Cajal Bodies & Gems

Cajal bodies or coiled bodies are dense foci of coilin protein. Gemini of Cajal bodies, or gems, are microscopically similar to Cajal bodies. It is believed that Cajal bodies play important roles in RNA processing while gems assist the Cajal bodies. Find the latest research on Cajal bodies and gems here.

Cancer Metabolic Reprogramming (Keystone)

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cancer -Omics

A variety of different high-throughput technologies can be used to identify the complete catalog of changes that characterize the molecular profile of cohorts of tumor samples. Discover the latest insights gained from cancer 'omics' in this feed.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.

Cancer Epigenetics and Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.